• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国人体血吸虫病(裂体吸虫病)的历史:从发现到消除。

History of Human Schistosomiasis (bilharziasis) in China: From Discovery to Elimination.

机构信息

Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.

Center for Tropical Disease Research, Fudan University, Shanghai, China.

出版信息

Acta Parasitol. 2021 Sep;66(3):760-769. doi: 10.1007/s11686-021-00357-9. Epub 2021 Mar 13.

DOI:10.1007/s11686-021-00357-9
PMID:33713275
Abstract

PURPOSE

For the evolution of schistosomiasis in China, a systematic review was provided about the history of the disease and its public health impacts. We aimed to depict the journey from disease discovery to elimination and the experience and lessons learned during the process.

METHODS

We systematically reviewed the Chinese history of schistosomiasis and its public health impacts and collected data on the disease by searching relevant books and articles.

RESULTS

An important milestone for the disease discovery is that Schistosoma japonicum eggs were identified in the two Chinese corpses dating back to around 2180 years ago. The earliest Chinese ancient book documented symptoms resembling schistosomiasis that could date back to about 4700 years ago. The first nationwide survey on the disease in the mid-1950s revealed that schistosomiasis was endemic in 433 counties or cities of 12 provinces and affected about 11.6 million people in China. The Chinese government has provided continuous investment in schistosoiasis control, and the national multifaceted, integrated control programs have been uninterruptedly implemented since 1955. Schistosomiasis control in China can be divided into six stages, and various schistosomiasis control strategies have been developed and adjusted. The number of schistosomiasis cases decreased from 11.6 million in 1950s to 38,000 in 2017 and the number of acute cases decreased from 13,191 in 1989 to only 1 in 2017.

CONCLUSIONS

Schistosomiasis transmission has been under control in all parts of China since 2017. An elimination of schistosomiasis can be achieved in the foreseeable future in China.

摘要

目的

为了了解中国血吸虫病的演变历程,本研究对该病的历史及其对公共卫生的影响进行了系统回顾。我们旨在描绘从发现疾病到消除疾病的历程,以及在此过程中积累的经验和教训。

方法

我们系统地回顾了中国血吸虫病的历史及其对公共卫生的影响,并通过搜索相关书籍和文章收集了该病的数据。

结果

疾病发现的一个重要里程碑是,在大约 2180 年前的两具中国古尸中发现了日本血吸虫卵。最早记录类似血吸虫病症状的中国古代书籍可以追溯到大约 4700 年前。20 世纪 50 年代中期进行的首次全国性疾病调查显示,血吸虫病在中国 12 个省的 433 个县或市流行,约有 1160 万人受到影响。中国政府一直持续投入于血吸虫病的防治,自 1955 年以来,国家多部门综合防治规划一直在不间断地实施。中国血吸虫病防治工作可以分为 6 个阶段,并且制定和调整了各种血吸虫病防治策略。从 20 世纪 50 年代的 1160 万例下降到 2017 年的 3.8 万例,急性血吸虫病病例数从 1989 年的 13191 例下降到 2017 年的 1 例。

结论

自 2017 年以来,中国各地的血吸虫病传播已得到控制。在可预见的未来,中国有望消除血吸虫病。

相似文献

1
History of Human Schistosomiasis (bilharziasis) in China: From Discovery to Elimination.中国人体血吸虫病(裂体吸虫病)的历史:从发现到消除。
Acta Parasitol. 2021 Sep;66(3):760-769. doi: 10.1007/s11686-021-00357-9. Epub 2021 Mar 13.
2
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.依那西普和英夫利昔单抗治疗银屑病关节炎:系统评价与经济学评估
Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. doi: 10.3310/hta10310.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.

引用本文的文献

1
Epidemiological Characteristics and Trends of Zoonotic Diseases in China from 2015 to 2022.2015年至2022年中国动物源性疾病的流行病学特征与趋势
Trop Med Infect Dis. 2025 Jun 9;10(6):159. doi: 10.3390/tropicalmed10060159.
2
Schistosomiasis and water resources development in Africa: A scoping review and multi-case evaluation of associated snail control.非洲的血吸虫病与水资源开发:相关钉螺控制的范围界定综述与多案例评估
PLoS Negl Trop Dis. 2025 Jun 12;19(6):e0013180. doi: 10.1371/journal.pntd.0013180. eCollection 2025 Jun.
3
Understanding the Feasibility to Implement Schistosomiasis Elimination Project Under China-Zimbabwe Cooperation: A Pilot Study Protocol.

本文引用的文献

1
Defeating Schistosomiasis.战胜血吸虫病
N Engl J Med. 2019 Dec 26;381(26):2567-2568. doi: 10.1056/NEJMe1913771.
2
Schistosomiasis - Assessing Progress toward the 2020 and 2025 Global Goals.血吸虫病 - 评估实现 2020 年和 2025 年全球目标的进展情况。
N Engl J Med. 2019 Dec 26;381(26):2519-2528. doi: 10.1056/NEJMoa1812165.
3
History of schistosomiasis (bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies.人体血吸虫病(裂体吸虫病)的历史:从埃及医学纸莎草纸到木乃伊的分子生物学。
了解中津合作实施血吸虫病消除项目的可行性:一项试点研究方案
J Epidemiol Glob Health. 2025 May 26;15(1):75. doi: 10.1007/s44197-025-00418-6.
4
Seropositive Rate and Associated Factors of Schistosomiasis in Hunan Province, China: A Three-Year Cross-Sectional Survey.中国湖南省血吸虫病血清阳性率及相关因素:一项为期三年的横断面调查
Acta Parasitol. 2025 Apr 16;70(3):94. doi: 10.1007/s11686-025-01033-y.
5
Population genetic diversity of Schistosoma japonicum arises from the host switching in the life cycle.日本血吸虫的群体遗传多样性源于其生命周期中的宿主转换。
PLoS Negl Trop Dis. 2025 Mar 19;19(3):e0012931. doi: 10.1371/journal.pntd.0012931. eCollection 2025 Mar.
6
Risk Prediction of Emerging Sites Infested with Schistosome-Transmitting Oncomelania hupensis in Shanghai, China.中国上海感染血吸虫传播中间宿主钉螺的新出现区域的风险预测
Am J Trop Med Hyg. 2025 Feb 4;112(4):804-815. doi: 10.4269/ajtmh.24-0200. Print 2025 Apr 2.
7
Changing seroprevalence of schistosomiasis japonica in China from 1982 to 2020: A systematic review and spatial analysis.1982 年至 2020 年中国日本血吸虫病血清流行率变化:系统评价和空间分析。
PLoS Negl Trop Dis. 2024 Sep 3;18(9):e0012466. doi: 10.1371/journal.pntd.0012466. eCollection 2024 Sep.
8
The genetic diversity of Oncomelania hupensis robertsoni, intermediate hosts of Schistosoma japonicum in hilly regions of China, using microsatellite markers.利用微卫星标记研究中国丘陵地区日本血吸虫中间宿主湖北钉螺的遗传多样性。
Parasit Vectors. 2024 Mar 21;17(1):147. doi: 10.1186/s13071-024-06227-3.
9
Prevalence of depressive symptoms in patients with advanced schistosomiasis in China: A systematic review and meta-analysis.中国晚期血吸虫病患者抑郁症状的患病率:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2024 Mar 7;18(3):e0012003. doi: 10.1371/journal.pntd.0012003. eCollection 2024 Mar.
10
Diterpenoids with Schistosomula-Killing and Anti-Fibrosis Activities In Vitro from the Leaves of .从. 的叶子中分离得到具有杀童虫和抗纤维化活性的二萜类化合物。
Molecules. 2024 Jan 13;29(2):401. doi: 10.3390/molecules29020401.
Pathog Glob Health. 2018 Jul;112(5):268-273. doi: 10.1080/20477724.2018.1495357. Epub 2018 Jul 17.
4
New Anti-Schistosoma Approaches in The People's Republic of China: Development of Diagnostics, Vaccines and Other New Techniques Belonging to the 'Omics' Group.中华人民共和国的新型抗血吸虫病方法:诊断技术、疫苗及其他 “组学” 相关新技术的研发
Adv Parasitol. 2016;92:385-408. doi: 10.1016/bs.apar.2016.02.007. Epub 2016 Apr 5.
5
Evolution of the National Schistosomiasis Control Programmes in The People's Republic of China.中华人民共和国国家血吸虫病防治规划的演变
Adv Parasitol. 2016;92:1-38. doi: 10.1016/bs.apar.2016.02.001. Epub 2016 Apr 13.
6
Enhancing collaboration between China and African countries for schistosomiasis control.加强中非血吸虫病防治合作。
Lancet Infect Dis. 2016 Mar;16(3):376-83. doi: 10.1016/S1473-3099(15)00360-6. Epub 2016 Feb 4.
7
Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis.撒哈拉以南非洲地区血吸虫病的空间分布和治疗需求:系统评价和地统计学分析。
Lancet Infect Dis. 2015 Aug;15(8):927-40. doi: 10.1016/S1473-3099(15)00066-3. Epub 2015 May 21.
8
Prehistoric schistosomiasis parasite found in the Middle East.在中东发现史前血吸虫寄生虫。
Lancet Infect Dis. 2014 Jul;14(7):553-4. doi: 10.1016/S1473-3099(14)70794-7.
9
Human schistosomiasis.人体血吸虫病。
Lancet. 2014 Jun 28;383(9936):2253-64. doi: 10.1016/S0140-6736(13)61949-2. Epub 2014 Apr 1.
10
Assessment of morbidity due to Schistosoma japonicum infection in China.中国日本血吸虫病感染所致发病率评估。
Infect Dis Poverty. 2014 Feb 14;3(1):6. doi: 10.1186/2049-9957-3-6.